Root-Bernstein R
Int J Mol Sci. 2024; 25(3).
PMID: 38339075
PMC: 10855694.
DOI: 10.3390/ijms25031797.
Root-Bernstein R, Huber J, Ziehl A, Pietrowicz M
Int J Mol Sci. 2023; 24(15).
PMID: 37569555
PMC: 10418384.
DOI: 10.3390/ijms241512177.
Nkoke C, Djibrilla S, Gobina R, Dzudie A
Eur Heart J Case Rep. 2023; 7(1):ytac480.
PMID: 36655139
PMC: 9838795.
DOI: 10.1093/ehjcr/ytac480.
Root-Bernstein R, Fairweather D
J Theor Biol. 2014; 375:101-123.
PMID: 25484004
PMC: 4417457.
DOI: 10.1016/j.jtbi.2014.11.022.
Root-Bernstein R
Front Pediatr. 2014; 2:85.
PMID: 25191648
PMC: 4137453.
DOI: 10.3389/fped.2014.00085.
The role of viral agents in aetiopathogenesis of acute rheumatic fever.
Olgunturk R, Okur I, Cirak M, Oguz A, Akalin N, Turet S
Clin Rheumatol. 2010; 30(1):15-20.
PMID: 20401762
DOI: 10.1007/s10067-010-1447-x.
Expression of an antigenic adenovirus epitope in a group B coxsackievirus.
Hofling K, Tracy S, Chapman N, Kim K, Leser J
J Virol. 2000; 74(10):4570-8.
PMID: 10775593
PMC: 111977.
DOI: 10.1128/jvi.74.10.4570-4578.2000.
Coxsackie virus infections in rheumatic fever.
Zaher S, Kassem A, Hughes J
Indian J Pediatr. 1993; 60(2):289-98.
PMID: 8244506
DOI: 10.1007/BF02822194.
Autoantibodies and serum inhibition factors (sif) in patients with myocarditis.
Maisch B, Berg P, Kochsiek K
Klin Wochenschr. 1980; 58(5):219-25.
PMID: 6995705
DOI: 10.1007/BF01476967.
Levamisole exacerbates coxsackievirus B3-induced murine myocarditis.
Gudvangen R, Duffey P, Paque R, Gauntt C
Infect Immun. 1983; 41(3):1157-65.
PMID: 6309663
PMC: 264621.
DOI: 10.1128/iai.41.3.1157-1165.1983.
Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.
Gauntt C, Paque R, Trousdale M, Gudvangen R, Barr D, Lipotich G
Infect Immun. 1983; 39(2):851-64.
PMID: 6299950
PMC: 348027.
DOI: 10.1128/iai.39.2.851-864.1983.
Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis.
Maisch B, Stechemesser E, Berg P, Kochsiek K
Clin Exp Immunol. 1982; 48(3):533-45.
PMID: 6288291
PMC: 1536618.
Discovery of cytomegalovirus in pericarditis fluid from a patient with neoplasm.
Etienne J, Matillon Y, Lehot L, Brune J, Chomel J, Gilbert R
Infection. 1982; 10(2):102.
PMID: 6284648
DOI: 10.1007/BF01816734.
Assessment of cell-mediated immunity against coxsackievirus B3-induced myocarditis in a primate model (Papio papio).
Paque R, Gauntt C, Nealon T
Infect Immun. 1981; 31(1):470-9.
PMID: 6260666
PMC: 351806.
DOI: 10.1128/iai.31.1.470-479.1981.
Evaluation of mild acute infectious myocarditis.
Heikkila J, Karjalainen J
Br Heart J. 1982; 47(4):381-91.
PMID: 6121567
PMC: 481151.
DOI: 10.1136/hrt.47.4.381.
Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains.
Gauntt C, Gomez P, Duffey P, Grant J, TRENT D, WITHERSPOON S
J Virol. 1984; 52(2):598-605.
PMID: 6092681
PMC: 254563.
DOI: 10.1128/JVI.52.2.598-605.1984.
Coxsackievirus B4: in vitro genetic markers and cardiovirulence. Brief report.
Jimes S, Jamison R, Grafton W
Arch Virol. 1984; 81(3-4):345-51.
PMID: 6089708
DOI: 10.1007/BF01310005.
The latent herpes simplex virus.
Docherty J, Chopan M
Bacteriol Rev. 1974; 38(4):337-55.
PMID: 4374179
PMC: 413863.
DOI: 10.1128/br.38.4.337-355.1974.
Hemodynamic studies and response to a combined therapy of nitroglycerin ointment and dopamine in patients with acute myocarditis.
Hiroe M, Sekiguchi M, Take M, Morimoto S, Ogasawara S, Matsuda M
Heart Vessels Suppl. 1985; 1:180-6.
PMID: 3939646
DOI: 10.1007/BF02072389.
Cardiovascular diseases due to viruses.
KAWANA R
Heart Vessels Suppl. 1985; 1:91-6.
PMID: 3843596
DOI: 10.1007/BF02072370.
